Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Polymorphonuclear elastase in human colorectal carcinoma.

Bjørnland K, Buø L, Scott H, Konttinen Y, Johansen HT, Aasen AO.

Int J Oncol. 1998 Mar;12(3):535-40.

PMID:
9472089
2.

Potentiative effects of neutral proteinases in an inflamed lung: relationship of neutrophil procollagenase (proMMP-8) to plasmin, cathepsin G and tryptase in bronchiectasis in vivo.

Sepper R, Konttinen YT, Buø L, Eklund KK, Lauhio A, Sorsa T, Tschesche H, Aasen AO, Sillastu H.

Eur Respir J. 1997 Dec;10(12):2788-93.

3.

Cleavage of plasma high molecular weight kininogen in surgical ICU patients.

Karlsrud TS, Buø L, Aasen AO, Johansen HT.

Intensive Care Med. 1996 Aug;22(8):760-5.

PMID:
8880244
4.

Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro.

Bjørnland K, Buø L, Kjønniksen I, Larsen M, Fodstad O, Johansen HT, Aasen AO.

Anticancer Res. 1996 Jul-Aug;16(4A):1627-31.

PMID:
8712680
5.

Bradykinin release from high molecular weight kininogen in surgical ICU patients.

Karlsrud TS, Buø L, Aasen AO, Johansen HT.

Immunopharmacology. 1996 Jun;33(1-3):365-8.

PMID:
8856188
6.

Interleukin-1 and collagenases around loosening total hip prostheses.

Konttinen YT, Kurvinen H, Takagi M, Michelsson JE, Eklund KK, Nordsletten L, Buø L, Aasen AO, Santavirta S.

Clin Exp Rheumatol. 1996 May-Jun;14(3):255-62.

PMID:
8809439
7.

Quantification of kininogens in plasma. A functional method based on the cysteine proteinase inhibitor activity.

Karlsrud TS, Buø L, Aasen AO, Johansen HT.

Thromb Res. 1996 May 1;82(3):265-73.

PMID:
8732630
8.

The plasminogen activation system is upregulated in loosening of total hip prostheses.

Nordsletten L, Buo L, Takagi M, Konttinen YT, Yamakawa M, Santavirta S, Aasen AO.

Acta Orthop Scand. 1996 Apr;67(2):143-8.

PMID:
8623568
9.

The fibrinolytic system in human ascites.

Buø L, Karlsrud TS, Dyrhaug G, Bell H, Engström L, Johansen HT, Aasen AO.

Scand J Gastroenterol. 1995 Nov;30(11):1101-7.

PMID:
8578171
10.
11.

Activation of the plasma contact system and hemodynamic changes after graft revascularization in liver transplantation.

Scholz T, Backman L, Mathisen O, Buø L, Karlsrud T, Johansen HT, Bergan A, Klintmalm GB, Aasen AO.

Transplantation. 1995 Jul 15;60(1):36-40.

PMID:
7542812
12.

Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.

Buø L, Bjørnland K, Karlsrud TS, Kvale D, Kjønniksen I, Fodstad O, Brandtzaeg P, Johansen HT, Aasen AO.

Anticancer Res. 1994 Nov-Dec;14(6B):2445-51.

PMID:
7872665
13.

Differential diagnosis of human ascites: inhibitors of the contact system and total proteins.

Buø L, Karlsrud TS, Dyrhaug G, Jacobsen MB, Bell H, Johansen HT, Aasen AO.

Scand J Gastroenterol. 1993 Sep;28(9):777-82.

PMID:
7694355
14.

The contact system in human malignant and benign ascites.

Buø L, Karlsrud TS, Johansen HT, Aasen AO.

Scand J Clin Lab Invest. 1993 Apr;53(2):117-24.

PMID:
7682333
15.

Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas.

Buø L, Lyberg T, Jørgensen L, Johansen HT, Aasen AO.

APMIS. 1993 Mar;101(3):235-41.

PMID:
8507461
16.

Activation of the plasma kallikrein-kinin system in respiratory distress syndrome.

Saugstad OD, Buø L, Johansen HT, Røise O, Aasen AO.

Pediatr Res. 1992 Oct;32(4):431-5.

PMID:
1437396
17.

Activation of the contact system in ascites from patients with gastrointestinal cancer.

Buø L, Karlsrud TS, Johansen HT, Aasen AO.

Agents Actions Suppl. 1992;38 ( Pt 2):237-48.

PMID:
1281373
18.

Characterization of kininogens in human malignant ascites.

Karlsrud TS, Buø L, Aasen AO, Johansen HT.

Thromb Res. 1991 Sep 15;63(6):641-50.

PMID:
1780808
19.

[The role of proteases in the growth, invasion and spread of cancer cells].

Buø L, Aasen AO, Karlsrud TS, Johansen HT, Sivertsen SM.

Tidsskr Nor Laegeforen. 1990 Nov 30;110(29):3753-6. Review. Norwegian.

PMID:
2274946

Supplemental Content

Support Center